G‐CSF Only Versus Chemotherapy and G‐CSF Peripheral Blood Stem Cell Mobilization for Autologous Hematopoietic Stem Cell Transplant—Assessing a Change in Regime due to the COVID‐19 Pandemic

Ähnliche Einträge

• Comparison of Peripheral Stem Cell Mobilization Results on the Fourth and Fifth Day of G‐CSF Treatment in Unrelated Donors
  von: Gulten Korkmaz, et al.
  Veröffentlicht: (2026)
• Preemptive Approach to Plerixafor Use Is Optimal in Patients With Relapsed/Refractory Germ Cell Tumors Undergoing Peripheral Blood Hematopoietic Stem Cell Collection: Effect on Collection Days, Yields, and Cost
  von: David O. Sohutskay, et al.
  Veröffentlicht: (2024)
• Multiday Use of Non‐Tunneled Central Venous Catheters in Vetted Adult Outpatients Undergoing Apheresis Collections of Autologous Peripheral Blood Stem Cells Is Feasible and Well Tolerated
  von: Andres E. Mindiola Romero, et al.
  Veröffentlicht: (2026)
• Cost‐Effectiveness of Preemptive Plerixafor Versus Rescue Plerixafor for Mobilization and Collection of Hematopoietic Stem Cells in Patients With Multiple Myeloma and Lymphoma
  von: Roselene Mesquita Augusto Passos, et al.
  Veröffentlicht: (2025)
• Transient Wavy Collection Trend in Hematopoietic Stem Cell Apheresis: A Rare and Underreported Occurrence
  von: Dibyajyoti Sahoo, et al.
  Veröffentlicht: (2025)